4 Market Pros Told Us Whether They'd Buy the SpaceX IPO

SpaceX is expected to go public in mid-June with about 30% of the IPO reportedly allocated to retail investors, but market pros are split on whether to buy on day one. Bulls point to the company's massive addressable market and founder Elon Musk, while bears highlight an expected $2 trillion valuation, $18 billion in revenue, and a nearly $5 billion net loss. The article suggests the IPO could draw strong retail interest, but near-term trading may be volatile and valuation-driven.

Analysis

The real tradeable issue is not whether SpaceX is “good,” but whether the float mechanics create a temporary scarcity premium that later mean-reverts. A retail-heavy book can support an aggressive first print, but as soon as lockups roll and early holders monetize, supply likely expands faster than incremental fundamental demand. That sets up a classic IPO path-dependency: strong opening momentum in days/weeks, followed by a much more difficult six-to-twelve month digestion period if revenue growth does not accelerate toward the valuation implied by the deal.

The second-order winner is not necessarily the issuer; it is passive capital. If inclusion prospects into broad benchmarks are credible, index and factor funds become forced buyers on a schedule, which can keep the stock bid even after valuation multiples look disconnected. That said, index support is a flow, not a thesis: it can delay downside, but it cannot prevent a long-duration de-rating if earnings visibility remains weak and the company stays structurally cash-flow negative.

The clearest contrarian point is that retail enthusiasm may be front-loading the full “option value” of the story before it has earned it. If the market prices SpaceX as a mature platform business rather than a capital-intensive venture, the downside from any execution miss is severe because there is little cushion in a $2T-type narrative. In that regime, the better expression is often to fade the multiple, not the company: wait for liquidity, then short the post-lockup air pocket or buy downside protection against a first-week spike that outruns the fundamental base.

Relative losers include listed high-growth mega-cap comparables and IPO-ecosystem names if SpaceX absorbs speculative capital that would otherwise rotate into other innovation trades. That effect is most visible in the near term through sentiment and flow, not immediate fundamentals, but it can still pressure names with similar “story stock” holders, especially if the IPO pricing prints rich and then de-risks the entire growth complex.

Key Decisions for Investors

• Do not chase the first-day print; wait 2-6 weeks post-IPO for insider-flow and implied volatility to normalize before establishing any position. Risk/reward is materially better after the opening scarcity premium fades.
• If access is available, buy short-dated downside protection on the IPO into lockup expiration; the setup favors a volatility crush followed by supply overhang. Target a 1:2 to 1:3 premium-to-protection profile.
• Relative-value pair: short the most expensive listed growth/innovation proxies against a basket of profitable mega-cap tech (e.g., short high-multiple peers, long MSFT/NVDA) if SpaceX trading lifts the whole complex. This isolates valuation compression from market beta.
• For investors who must participate, use a staged entry: 25% size at debut, add only on a 10-15% post-listing pullback if fundamentals and secondary demand remain intact. This reduces the probability of paying the peak scarcity premium.
• Set a calendar alert for lockup expiry and benchmark inclusion windows; those are the highest-conviction catalysts. If the stock is still trading at a valuation unsupported by credible near-term cash-flow inflection, that is the point to reduce exposure or initiate a short.